Executive Insights for Life Sciences Innovators
Executive Insights features conversations with visionary leaders shaping the future of biotech, pharma, medtech, diagnostics, and tools. Hear from CEOs, entrepreneurs, and investors about building companies, raising capital, and driving innovation. Whether you are growing a startup or scaling a global life sciences business, these candid discussions deliver the insights you need to succeed.
Episodes
In this episode of Executive Insights for Life Sciences Innovators, we speak with Jim Buck, President & CEO of Medcura, a medical device company advancing surgical safety through innovative hemostatic and wound treatment solutions.
Jim discusses how Medcura is addressing one of healthcare’s most persistent challenges, rapid and reliable bleeding control, through a platform built on biocompatible, naturally derived polymers. He s...
In this episode of Executive Insights for Life Sciences Innovators, we speak with Mike Stocum of Bantam Pharmaceutical, a biotech developing therapies that target cancer cells through their mitochondria. Mike shares how Bantam is advancing its lead programs and building a strategy to translate cutting-edge science into new treatment options for patients.
Learn more at genecoda.com.
Originally recorded and streamed on YouTube Li...
In this episode of Executive Insights for Life Sciences Innovators, we speak with Mark Stead of Atomic AI, a biotech harnessing artificial intelligence and structural biology to unlock RNA’s therapeutic potential. Mark shares how Atomic AI is building a discovery platform to model RNA structures with unprecedented accuracy, opening the door to new classes of medicines for oncology, rare diseases, and beyond.
Learn more at genecoda.c...
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Larry Tiffany, CEO of GenrAb, to explore how the company is developing fully human neuroprotective antibodies to address neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. Larry discusses GenrAb’s scientific approach, the promise of neuroprotection in slowing disease progression, and the challenges of advancing novel biologics in...
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Saurabh Johri, Chief Business Officer at Catena Biosciences, a pioneering company revolutionizing protein conjugation technologies for next-generation therapeutics. Saurabh shares insights on Catena’s platform, its potential to reshape therapeutic development, and the company’s vision for advancing precision medicine through novel protein engineeri...
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Darren Dasburg, CEO of Clarus Biologics, a company advancing vaccine and immunology innovation through a novel adjuvant platform designed to improve immune responses, particularly in vulnerable populations. Darren shares insights on Clarus Biologics’ technology, its potential applications in global health, and the company’s strategy for bringing no...
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Ayla Annac, CEO and Co-Founder of InvivoSciences, a precision medicine company transforming the way therapies are discovered and developed for heart failure and cardiometabolic diseases. Ayla shares insights into InvivoSciences’ innovative platform, the promise of patient-specific models in drug discovery, and the company’s vision for advancing pre...
Anna Kazanchyan, MD | CEO, Saghmos Therapeutics – Cardiovascular and Kidney Protection with ST-62516
In this episode of Executive Insights for Life Sciences Innovators, we speak with Anna Kazanchyan, MD, CEO of Saghmos Therapeutics, about the company’s mission to revolutionize cardiovascular and kidney protection. We explore how their lead drug candidate, ST-62516, is designed to prevent Major Adverse Cardiac and Kidney Events (MACKE) in high-risk patients undergoing PCI. Dr. Kazanchyan discusses the science behind ST-62516, why i...
In this episode of Executive Insights for Life Sciences Innovators, we speak with Charles Swindell, CEO of Glycotest, about the company’s proprietary technology that measures glycoprotein fucosylation for the detection of liver diseases. Charles shares insights on the science behind Glycotest’s platform, the challenges of bringing diagnostic innovation to market, and the future of precision liver disease detection.
Learn more at gen...
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.
Learn more at genecoda.com.
Originally re...
In this episode of Executive Insights for Life Sciences Innovators, we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics, about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences.
Learn more at genecoda.com.
This conversation w...
Popular Podcasts
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
In 1997, actress Kristin Davis’ life was forever changed when she took on the role of Charlotte York in Sex and the City. As we watched Carrie, Samantha, Miranda and Charlotte navigate relationships in NYC, the show helped push once unacceptable conversation topics out of the shadows and altered the narrative around women and sex. We all saw ourselves in them as they searched for fulfillment in life, sex and friendships. Now, Kristin Davis wants to connect with you, the fans, and share untold stories and all the behind the scenes. Together, with Kristin and special guests, what will begin with Sex and the City will evolve into talks about themes that are still so relevant today. "Are you a Charlotte?" is much more than just rewatching this beloved show, it brings the past and the present together as we talk with heart, humor and of course some optimism.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.